drugset / Trial / NCT01742000

Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women

NCT01742000 ↗

Phase 3 Completed 180 enrolled Institute for Atherosclerosis Research, Russia
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to investigate the anti-atherosclerotic action of natural drug Karinat based on phytoestrogen-rich botanicals in postmenopausal women.

Timeline

Start
2007-01
Primary completion
2012-06
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Karinat Traditional medicine (herbal / TCM) 500 mg Oral

Indications